← Eichor
Study identifier: NCT06382493 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Tegoprazan-containing Sequential for H. Pylori

Condition: Helicobacter Pylori Infection  ·  Sponsor: Seoul National University Bundang Hospital

PhaseNA
Planned participants400
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

As H. pylori eradication, the investigators prepared a randomized controlled clinical trial whether tegoprazan-containing 10-day sequential treatment was effective compared to conventional PPI-containing 10-day sequential eradication therapy

This description comes directly from the study's public registry record.

Talk to the study team

Jungwon Lee, Dr.  ·  821093567758  ·  saludos@naver.com

Always discuss trial participation with your own doctor first.

Locations (1)

Seoul National University Bundang HospitalSeongnam-si, Gyeonggi-do, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06382493